NCT00002365View on ClinicalTrials.gov

A Study of LXR015-1 in HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

LXR015-1

Trial Locations (1)

94705

East Bay AIDS Ctr, Berkeley

Sponsors

Lead Sponsor

LXR Biotechnology

All Listed Sponsors

lead

LXR Biotechnology

INDUSTRY

NCT00002365 - A Study of LXR015-1 in HIV-Infected Patients | Biotech Hunter | Biotech Hunter